We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$152B
AUM Growth
+$8.01B
Cap. Flow
-$3.16B
Cap. Flow %
-2.08%
Top 10 Hldgs %
10.95%
Holding
6,236
New
317
Increased
2,478
Reduced
1,864
Closed
264

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.68%
3 Healthcare 11.9%
4 Industrials 11.13%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRF
2926
DELISTED
NorthStar Realty Finance Corp.
NRF
$213K ﹤0.01%
11,654
+407
+4% +$7.42K
RSE
2927
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$213K ﹤0.01%
10,341
-4
-0% -$80
NBIX icon
2928
Neurocrine Biosciences
NBIX
$16.9B
$212K ﹤0.01%
18,730
-76,553
-80% -$1.05M
XBI icon
2929
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$212K ﹤0.01%
4,932
+1,020
+26% +$41.3K
BTZ icon
2930
BlackRock Credit Allocation Income Trust
BTZ
$933M
$211K ﹤0.01%
16,144
-1,746
-10% -$22K
OKS
2931
DELISTED
Oneok Partners LP
OKS
$211K ﹤0.01%
3,973
-195
-5% -$9.89K
GSAT icon
2932
Globalstar
GSAT
$10.8B
$210K ﹤0.01%
12,879
-7,719
-37% -$126K
FEO
2933
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$210K ﹤0.01%
11,013
PXE icon
2934
Invesco Energy Exploration & Production ETF
PXE
$83.4M
$208K ﹤0.01%
6,828
-734
-10% -$22.4K
SAFE
2935
Safehold
SAFE
$1.16B
$208K ﹤0.01%
3,538
+546
+18% +$30.6K
PMCS
2936
DELISTED
P M C SIERRA INC
PMCS
$208K ﹤0.01%
31,390
+12,189
+63% +$79.8K
OMED
2937
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$207K ﹤0.01%
+13,500
New +$250K
DBP icon
2938
Invesco DB Precious Metals Fund
DBP
$237M
$206K ﹤0.01%
4,707
-16
-0.3% -$698
NCZ
2939
Virtus Convertible & Income Fund II
NCZ
$296M
$206K ﹤0.01%
5,974
-3
-0.1% -$104
HYV
2940
DELISTED
BALCKROCK CORP HG YLD FD V INC
HYV
$206K ﹤0.01%
17,005
+875
+5% +$10.4K
FAX
2941
abrdn Asia-Pacific Income Fund
FAX
$595M
$205K ﹤0.01%
31,101
-20,701
-40% -$136K
SLX icon
2942
VanEck Steel ETF
SLX
$169M
$204K ﹤0.01%
4,537
+464
+11% +$19.7K
BN icon
2943
Brookfield
BN
$107B
$203K ﹤0.01%
23,142
+1,704
+8% +$14.5K
NIO
2944
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
$202K ﹤0.01%
16,035
+880
+6% +$11.5K
AGM icon
2945
Federal Agricultural Mortgage
AGM
$2.58B
$200K ﹤0.01%
5,992
-300
-5% -$9.75K
FEM icon
2946
First Trust Emerging Markets AlphaDEX Fund
FEM
$747M
$200K ﹤0.01%
8,214
+2,706
+49% +$64.4K
PSF icon
2947
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$199K ﹤0.01%
8,305
+3,130
+60% +$77.7K
RPT
2948
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$199K ﹤0.01%
12,921
+5,775
+81% +$88.7K
ECYT
2949
DELISTED
Endocyte, Inc. Common Stock
ECYT
$198K ﹤0.01%
14,909
OVTI
2950
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$198K ﹤0.01%
12,930

Similar funds

Ameriprise's Q3 2013 Portfolio in Review

As of Q3 2013, Ameriprise held 6,236 positions worth $152B, up 5.5% from $144B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Ameriprise's Q3 2013 filing shows 317 new, 2,478 increased, 1,864 reduced and 264 closed positions. Its largest new stake was Wells Fargo & Co.: 830,000 shares worth $19.8M. The largest sale was Edwards Lifesciences, an estimated $333M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Ameriprise's largest Q3 2013 buy was Wells Fargo & Co.: 830,000 shares worth $19.8M.
  • Ameriprise added most to ConocoPhillips in Q3 2013, an estimated $268M increase.
  • Ameriprise's biggest Q3 2013 reduction was Edwards Lifesciences, cutting an estimated $333M.
  • Ameriprise fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $235M.
  • Ameriprise's ten largest holdings make up 11% of its $152B portfolio in Q3 2013.
  • Ameriprise opened 317 new positions and closed 264 in Q3 2013.
  • Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $152B.

Based on Ameriprise's 13F filing for Q3 2013, filed 14 Nov 2013.